• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aging Clin Exp Res . Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment

tetano

Editor, Senior Moderator
Aging Clin Exp Res


. 2022 Jan 11.
doi: 10.1007/s40520-021-02042-3. Online ahead of print.
Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment


Viviana Cristillo[SUP] 1 [/SUP], Andrea Pilotto[SUP] 2 [/SUP], Stefano Cotti Piccinelli[SUP] 2 [/SUP], Giulio Bonzi[SUP] 2 [/SUP], Antonio Canale[SUP] 3 [/SUP], Stefano Gipponi[SUP] 2 [/SUP], Michela Bezzi[SUP] 4 [/SUP], Matilde Leonardi[SUP] 5 [/SUP], Alessandro Padovani[SUP] 2 [/SUP], Neuro Covid Next Study group



Collaborators, Affiliations

Abstract

Background: Cognitive deficits have been increasingly reported as possible long-term manifestations after SARS-CoV-2 infection.
Aims: In this study we aimed at evaluating the factors associated with cognitive deficits 6 months after hospitalization for Coronavirus Disease 2019 (COVID-19).
Methods: One hundred and six patients, discharged from a pneumology COVID-19 unit between March 1 and May 30 2020, accepted to be evaluated at 6 months according to an extensive neurological protocol, including the Montreal Cognitive Assessment (MoCA).
Results: Abnormal MoCA scores at 6 months follow-up were associated with higher pre-hospitalization National Health System (NHS) score (Duca et al. in Emerg Med Pract 22:1-2, 2020) (OR 1.27; 95% CI 1.05-1.6; p = 0.029) and more severe pulmonary disease expressed by the Brescia-COVID Respiratory Severity Scale (Duca et al. in Emerg Med Pract 22:1-2, 2020) (BCRSS > 1OR 4.73; 95% CI 1.53-14.63; p = 0.003) during the acute phase of the disease.
Discussion: This longitudinal study showed that the severity of COVID-19, indicated by BCRSS, and a complex score given by age and premorbid medical conditions, expressed by NHS, play a major role in modulating the long-term cognitive consequences of COVID-19 disease.
Conclusions: These findings indicate that the association of age and premorbid factors might identify people at risk for long-term neurological consequences of COVID-19 disease, thus deserving longer and proper follow-up.

Keywords: COVID-19; Cognitive functions; Long-COVID; Neurology.
 
Back
Top Bottom